Assignee
MERCK SHARP & DOHME
US·1,534 granted patents·315 pending applications·13,476 citations·filing 1973–2025
Top patents by PatentIndex Score
1,849 records- 0198US10188730B2Anti-LAG3 antibodies and antigen-binding fragmentsMERCK SHARP & DOHME·Filed 2017·Granted Jan 29, 2019·42 cites·41 claims
- 0298US5514718AHeterocyclic compounds, processes for their preparation and pharmaceutical compositions containing themMERCK SHARP & DOHME·Filed 1994·Granted May 7, 1996·551 cites·12 claims
- 0397US11091493B2Process for preparing beta 3 agonists and intermediatesMERCK SHARP & DOHME·Filed 2020·Granted Aug 17, 2021·6 cites·11 claims
- 0497US10106574B2Cyclic di-nucleotide compounds as sting agonistsMERCK SHARP & DOHME·Filed 2016·Granted Oct 23, 2018·34 cites·34 claims
- 0597US9586934B22-pyridyloxy-4-methyl orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2014·Granted Mar 7, 2017·25 cites·14 claims
- 0697USD780909SAutoinjector penMERCK SHARP & DOHME·Filed 2014·Granted Mar 7, 2017·104 cites·1 claims
- 0797US8952136B2Antibodies to human programmed death receptor PD-1MERCK SHARP & DOHME·Filed 2012·Granted Feb 10, 2015·174 cites·3 claims
- 0897US8900587B2Antibodies to human programmed death receptor PD-1MERCK SHARP & DOHME·Filed 2012·Granted Dec 2, 2014·411 cites·3 claims
- 0997US7951797B2Substituted diazepan orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2007·Granted May 31, 2011·59 cites·9 claims
- 1096US11925709B2Tablet formulation for CGRP active compoundsMERCK SHARP & DOHME·Filed 2020·Granted Mar 12, 2024·12 cites·10 claims
- 1196US11124478B2Process for making beta 3 agonists and intermediatesMERCK SHARP & DOHME·Filed 2020·Granted Sep 21, 2021·5 cites·5 claims
- 1296US10696681B2Process for preparing beta 3 agonists and intermediatesMERCK SHARP & DOHME·Filed 2019·Granted Jun 30, 2020·7 cites·5 claims
- 1396USD857192SAutoinjector deviceMERCK SHARP & DOHME·Filed 2016·Granted Aug 20, 2019·75 cites·1 claims
- 1496US10323090B2PD1 and/or LAG3 bindersMERCK SHARP & DOHME·Filed 2016·Granted Jun 18, 2019·26 cites·31 claims
- 1596US10189831B2Non-nucleoside reverse transcriptase inhibitorsMERCK SHARP & DOHME·Filed 2017·Granted Jan 29, 2019·75 cites·17 claims
- 1696US10106541B2Intermediates for preparing CGRP receptor antagonistsMERCK SHARP & DOHME·Filed 2017·Granted Oct 23, 2018·16 cites·5 claims
- 1796US9833448B2Piperidinone carboxamide azaindane CGRP receptor antagonistsMERCK SHARP & DOHME·Filed 2016·Granted Dec 5, 2017·18 cites·1 claims
- 1896US9624197B22-pyridylamino-4-nitrile-piperidinyl orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2013·Granted Apr 18, 2017·24 cites·11 claims
- 1996US9617246B2Thioether-piperidinyl orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2014·Granted Apr 11, 2017·18 cites·14 claims
- 2096US9556190B2Piperidinyloxy lactone orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2014·Granted Jan 31, 2017·18 cites·16 claims
- 2196US9174989B2Process for making CGRP receptor antagonistsMERCK SHARP & DOHME·Filed 2013·Granted Nov 3, 2015·19 cites·11 claims
- 2296US7973040B2Macrocyclic quinoxaline compounds as HCV NS3 protease inhibitorsMERCK SHARP & DOHME·Filed 2009·Granted Jul 5, 2011·40 cites·12 claims
- 2396US5885999ASerine derivatives and their use as therapeutic agentsMERCK SHARP & DOHME·Filed 1997·Granted Mar 23, 1999·103 cites·19 claims
- 2496US4377588A4-(Substituted thiazolyl)-3-hydroxy-3-pyrroline-2,5-dione inhibitors of glycolic acid oxidaseMERCK SHARP & DOHME·Filed 1979·Granted Mar 22, 1983·37 cites·7 claims
- 2595US11767292B2Process for making beta 3 agonists and intermediatesMERCK SHARP & DOHME·Filed 2021·Granted Sep 26, 2023·3 cites·12 claims
- 2695US11708371B2Process for making beta 3 agonists and intermediatesMERCK SHARP & DOHME·Filed 2021·Granted Jul 25, 2023·3 cites·13 claims
- 2795US11649243B2Process for preparing beta 3 agonists and intermediatesMERCK SHARP & DOHME·Filed 2021·Granted May 16, 2023·3 cites·9 claims
- 2895US10899771B2Process for making beta 3 agonists and intermediatesMERCK SHARP & DOHME·Filed 2019·Granted Jan 26, 2021·7 cites·4 claims
- 2995US10577316B2Process for making beta 3 agonists and intermediatesMERCK SHARP & DOHME·Filed 2017·Granted Mar 3, 2020·9 cites·23 claims
- 3095US9850246B2Process for making CGRP receptor antagonistsMERCK SHARP & DOHME·Filed 2015·Granted Dec 26, 2017·17 cites·3 claims
- 3195US9822138B2Antiviral beta-amino acid ester phosphodiamide compoundsMERCK SHARP & DOHME·Filed 2016·Granted Nov 21, 2017·12 cites·81 claims
- 3295US9718818B2Compounds inhibiting leucine-rich repeat kinase enzyme activityMERCK SHARP & DOHME·Filed 2014·Granted Aug 1, 2017·25 cites·9 claims
- 3395US9586950B22-pyridyloxy-3-ester-4-nitrile orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2013·Granted Mar 7, 2017·17 cites·12 claims
- 3495US9556145B22-pyridyloxy-4-ester orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2013·Granted Jan 31, 2017·17 cites·15 claims
- 3595US9550786B24-fluoropiperidine orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2014·Granted Jan 24, 2017·17 cites·12 claims
- 3695US9546152B22-pyridyloxy-3-substituted-4-nitrile orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2013·Granted Jan 17, 2017·17 cites·13 claims
- 3795US9499545B2Piperidinone carboxamide azaindane CGRP receptor antagonistsMERCK SHARP & DOHME·Filed 2014·Granted Nov 22, 2016·21 cites·3 claims
- 3895US8362212B2Engineered anti-IL-23 antibodiesMERCK SHARP & DOHME·Filed 2009·Granted Jan 29, 2013·26 cites·18 claims
- 3995US7951795B2Constrained spirocyclic compounds as CGRP receptor antagonistsMERCK SHARP & DOHME·Filed 2007·Granted May 31, 2011·43 cites·12 claims
- 4095US7879815B2Nucleoside aryl phosphoramidates for the treatment of RNA-dependent RNA viral infectionMERCK SHARP & DOHME·Filed 2007·Granted Feb 1, 2011·132 cites·18 claims
- 4195US6479480B1Phenylindole derivatives as 5-ht2a receptor ligandsMERCK SHARP & DOHME·Filed 1999·Granted Nov 12, 2002·89 cites·8 claims
- 4295US6448229B2Gamma secretase inhibitorsMERCK SHARP & DOHME·Filed 2001·Granted Sep 10, 2002·54 cites·9 claims
- 4395US5614532AQuinolone derivativesMERCK SHARP & DOHME·Filed 1992·Granted Mar 25, 1997·75 cites·7 claims
- 4495US5614518AMorpholine derivatives as dopamine receptor subtype ligandsMERCK SHARP & DOHME·Filed 1994·Granted Mar 25, 1997·66 cites·9 claims
- 4595US5556969ABenzodiazepine derivativesMERCK SHARP & DOHME·Filed 1995·Granted Sep 17, 1996·94 cites·7 claims
- 4694US10766919B2Cyclic di-nucleotide compounds as sting agonistsMERCK SHARP & DOHME·Filed 2018·Granted Sep 8, 2020·9 cites·15 claims
- 4794US10618958B2Anti-TIGIT antibodiesMERCK SHARP & DOHME·Filed 2017·Granted Apr 14, 2020·10 cites·32 claims
- 4894US10550190B2Phosphate based linkers for intracellular delivery of drug conjugatesMERCK SHARP & DOHME·Filed 2015·Granted Feb 4, 2020·13 cites·4 claims
- 4994USD870270SAutoinjector penMERCK SHARP & DOHME·Filed 2017·Granted Dec 17, 2019·48 cites·1 claims
- 5094US10272077B2Piperidinone carboxamide azaindane CGRP receptor antagonistsMERCK SHARP & DOHME·Filed 2017·Granted Apr 30, 2019·16 cites·19 claims
Showing the top 50 of 1,849 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when MERCK SHARP & DOHME files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →